NIH Study Finds Tecovirimat Was Safe but Did Not Improve Mpox Resolution or Pain

News Healthcare & Pharma General Updates

Date: 10th Dec, 2024 Source: National Institutes of Health (NIH) Country: USA Original Source

Brief

"On Tuesday, December 10, 2024, the National Institutes of Health (NIH) issued an update regarding NIH Study Finds Tecovirimat Was Safe but Did Not Improve Mpox Resolution or Pain. The study, called STOMP, found that tecovirimat did not reduce the time to lesion resolution or have an effect on pain among adults with mild to moderate clade II mpox, although it was safe and had no safety concerns."

This content is restricted.

Highlights content goes here...

This content is restricted.

National Institutes of Health (NIH)

RADA.AI

Hello! I'm RADA.AI - Regulatory Analysis and Decision Assistance. Your Intelligent guide for compliance and decision-making. How can i assist you today?

Suggested

NIH Study Finds Tecovirimat Was Safe but Did Not Improve Mpox Resolution or Pain

Brief

National Institutes of Health (NIH)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.

NIH Study Finds Tecovirimat Was Safe but Did Not Improve Mpox Resolution or Pain

Brief

National Institutes of Health (NIH)

Form successfully submitted. One of our GRI rep will contact you shortly

Thanking You!

Enter your Email

Verify OTP

Enter your Email

Verify Email

Tell us more about yourself

Select your work area

Select your country

All set.